EAU Update on Prostate Cancer (PCa19)

Urology - General
Oct 11, 2019 - Oct 12, 2019


Unique with its fully interactive format, prostate cancer experts from across Europe will challenge participants with a critical assessment of standard and prospective PCa therapies. In collaboration with the European School of Urology (ESU), the two-day program will examine key topics in optimal PCa management.

From insightful overviews to point-by-point assessment of treatment strategies, expert lecturers will take participants through a range of issues on current guidelines, clinical dilemmas, and medical management. Stock knowledge will be tested against the impact of new drug research and evolving use of imaging technologies. With incisive, to-the-point commentary, the faculty will tackle systemic treatments, metastatic disease, drug sequencing and complications management.

While emphasizing evidence-based medicine, interactive breakout sessions will explore difficulties in diagnosis, use of imaging tools, and effective follow-up strategies. Case discussions and topic-focused sessions led by a rotating faculty will aim for in-depth inquiry into contentious issues such as local salvage therapy, active surveillance and managing recurrent disease.

Location: Clarion Congress Hotel, Prague, Czechia 

2019 Program